Company intelligence / Profile preview

Evon Medics

Ellicott City, Maryland, United Statesevonmedics.com ↗

Ownership: Private
Employees: ~11
Development stage: Phase 2

Overview

The company’s Computerized Olfactory Training medical device has shown encouraging results in a pilot study for Alzheimer’s disease and received a $2.5 million NIH SBIR Phase II grant to support pivotal clinical trials. The technology aims to provide non-invasive home-based treatment by stimulating the primary olfactory cortex to increase neuroplasticity and improve cognitive function.

Therapeutic areas: PsychiatryNeurology
Modalities: DeviceNon-pharmacological therapy (Computerized Olfactory Training)
Industry: Therapeutic Medical Devices

Drug pipeline

2 assets

CBOT-P

Phase 2

Indications: Chronic Pain

1 more asset in the full pipeline.

Request access →

Partnerships

Howard University (research/trials)Several Maryland/DC area clinics/treatment centers (research/trials)

Beyond the preview

Go deeper on Evon Medics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evon Medics.

Explore the full profile